Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulation Treatment of Patients With Gastroesophageal Varices and JAK2 V617 Mutation

NCT04527666 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT04527666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04527666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulation Treatment of Patients With Gastroesophageal Varices and JAK2 V617 Mutation
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2020
Completion date
September 30, 2022
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal varices, jak2 mutation, myeloproliferative neoplasm